NASDAQ:INSY

INSYS Therapeutics SEC Filings & 10K Form

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range N/A
50-Day Range
$0.23
MA: $23,687,640.18
$65,799,000.00
52-Week Range N/A
VolumeN/A
Average Volume9.52 million shs
Market Capitalization$21.71 million
P/E RatioN/A
Dividend YieldN/A
Beta3.21

SEC Filings

INSYS Therapeutics (NASDAQ:INSY) SEC Filings

DateFilerForm TypeView
02/11/2020
4:00 PM
INSYS Therapeutics (Filer)
Form 15-12B
02/10/2020
8:54 AM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2020
4:25 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2020
4:04 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2020
3:29 PM
INSYS Therapeutics (Filer)
Form S-8 POS
01/03/2020
3:27 PM
INSYS Therapeutics (Filer)
Form S-8 POS
01/03/2020
3:26 PM
INSYS Therapeutics (Filer)
Form S-8 POS
12/26/2019
4:27 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2019
4:29 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2019
3:23 PM
INSYS Therapeutics (Filer)
Form NT 10-Q
11/20/2019
4:21 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2019
1:33 PM
ETF MANAGERS GROUP, LLC (Filed by)
INSYS Therapeutics (Subject)
Form SC 13G
11/04/2019
5:07 AM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2019
5:04 AM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2019
1:55 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2019
1:55 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2019
5:04 AM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2019
3:26 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2019
1:07 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2019
5:03 AM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2019
3:30 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2019
12:41 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
4:17 PM
INSYS Therapeutics (Filer)
Form NT 10-Q
08/08/2019
4:08 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2019
10:52 AM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2019
3:00 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2019
8:37 AM
INSYS Therapeutics (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
06/10/2019
7:00 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2019
6:18 AM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2019
1:08 PM
INSYS Therapeutics (Filer)
Form 8-K/A
06/06/2019
4:11 PM
Housley Andrece (Reporting)
INSYS Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
4:09 PM
Housley Andrece (Reporting)
INSYS Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/05/2019
8:42 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2019
4:31 PM
INSYS Therapeutics (Issuer)
Long Andrew G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
4:18 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
8:44 PM
INSYS Therapeutics (Filer)
Form NT 10-Q
05/10/2019
8:04 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
3:14 PM
INSYS Therapeutics (Filer)
Form 10-K/A
04/29/2019
11:36 AM
ETF MANAGERS GROUP, LLC (Filed by)
INSYS Therapeutics (Subject)
Form SC 13G/A
04/23/2019
6:16 PM
BOHLEN ELIZABETH (Reporting)
INSYS Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
6:15 PM
INSYS Therapeutics (Issuer)
Mahboob Vaseem (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
6:15 PM
INSYS Therapeutics (Issuer)
Nance Mark E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
6:14 PM
INSYS Therapeutics (Issuer)
Vanhove Geertrui (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
6:13 PM
INSYS Therapeutics (Issuer)
Vanhove Geertrui (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/23/2019
6:12 PM
INSYS Therapeutics (Issuer)
Motahari Saeed (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
6:11 PM
INSYS Therapeutics (Issuer)
Long Andrew G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
6:10 PM
INSYS Therapeutics (Issuer)
MEYER STEVEN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
6:09 PM
INSYS Therapeutics (Issuer)
LAPALME PIERRE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
6:07 PM
INSYS Therapeutics (Issuer)
Vishnoi Rohit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
4:21 PM
INSYS Therapeutics (Filer)
Form 8-K/A
04/23/2019
4:18 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2019
8:46 PM
INSYS Therapeutics (Issuer)
Vishnoi Rohit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2019
8:41 PM
INSYS Therapeutics (Issuer)
Long Andrew G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2019
8:40 PM
INSYS Therapeutics (Issuer)
Motahari Saeed (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2019
8:38 PM
INSYS Therapeutics (Issuer)
Nance Mark E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2019
8:35 PM
INSYS Therapeutics (Issuer)
Mahboob Vaseem (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2019
8:34 PM
BOHLEN ELIZABETH (Reporting)
INSYS Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2019
8:32 PM
INSYS Therapeutics (Issuer)
LAPALME PIERRE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2019
8:31 PM
INSYS Therapeutics (Issuer)
MEYER STEVEN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2019
8:30 PM
INSYS Therapeutics (Issuer)
Vanhove Geertrui (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2019
8:28 PM
INSYS Therapeutics (Issuer)
Vanhove Geertrui (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/18/2019
4:20 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2019
8:52 PM
INSYS Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2019
3:13 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2019
10:24 AM
ETF MANAGERS GROUP, LLC (Filed by)
INSYS Therapeutics (Subject)
Form SC 13G/A
02/26/2019
12:22 PM
ETF MANAGERS GROUP, LLC (Filed by)
INSYS Therapeutics (Subject)
Form SC 13G/A
02/19/2019
1:05 PM
ETF MANAGERS GROUP, LLC (Filed by)
INSYS Therapeutics (Subject)
Form SC 13G
11/09/2018
12:45 PM
INSYS Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2018
3:51 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2018
3:43 PM
INSYS Therapeutics (Issuer)
Nance Mark E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/12/2018
3:42 PM
INSYS Therapeutics (Issuer)
Nance Mark E (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/09/2018
3:13 PM
BOHLEN ELIZABETH (Reporting)
INSYS Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2018
1:48 PM
INSYS Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2018
4:24 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2018
2:10 PM
INSYS Therapeutics (Issuer)
Long Andrew G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2018
4:50 PM
INSYS Therapeutics (Issuer)
Tambi Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2018
4:03 PM
INSYS Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2018
1:55 PM
INSYS Therapeutics (Issuer)
Vishnoi Rohit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2018
1:54 PM
INSYS Therapeutics (Issuer)
LAPALME PIERRE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2018
1:53 PM
INSYS Therapeutics (Issuer)
MEYER STEVEN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2018
1:27 PM
INSYS Therapeutics (Issuer)
Motahari Saeed (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2018
3:27 PM
INSYS Therapeutics (Filer)
Form DEF 14A
04/02/2018
12:27 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2018
5:24 PM
INSYS Therapeutics (Issuer)
Insys Therapeutics, Inc. Voting Trust (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/08/2018
4:29 PM
INSYS Therapeutics (Subject)
Insys Therapeutics, Inc. Voting Trust (Filed by)
Form SC 13D
03/01/2018
5:00 PM
INSYS Therapeutics (Issuer)
JOHN N KAPOOR TRUST DATED SEPTEMBER 20 1989 (Reporting)
KAPOOR JOHN N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2018
7:40 AM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2018
1:45 PM
INSYS Therapeutics (Issuer)
Mahboob Vaseem (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2018
1:44 PM
INSYS Therapeutics (Issuer)
Mahboob Vaseem (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/16/2018
3:47 PM
INSYS Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/13/2018
3:42 PM
INSYS Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
02/01/2018
2:05 PM
INSYS Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2017
12:59 PM
INSYS Therapeutics (Filer)
Form CT ORDER
This page was last updated on 4/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.